A Minnesota urinary incontinence treatment company is now expanding to treat that other voiding dysfunction. Uroplasty (NASDAQ CM:UPI) announced Thursday that it is testing its Urgent PC Neuromodulation treatment for overactive bladders to now treat fecal incontinence. The company will launch a clinical trial in late summer in the U.S. The office-based, minimally invasive treatment is […]
Urinary incontinence products maker Uroplasty (NASDAQ:UPI) announced Monday that two private payers have agreed to cover its overactive bladder treatment. The Minnetonka, Minnesota-based urology firm has been winning coverage for its Urgent PC Neuromodulation treatment, which began with getting reimbursement from Medicare in November. And Wall Street has noticed. In the past year, the stock […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.